Clinical phenotypes and biologic treatment use in juvenile dermatomyositis-associated calcinosis

• Hauptverfasser: Amir B. Orandi (Verfasst von), Vikas R. Dharnidharka (Verfasst von), Noor Al-Hammadi (Verfasst von), Kevin W. Baszis (Verfasst von), for the CARRA Legacy Registry Investigators (Verfasst von)
• Format: Buch
• Veröffentlicht: BMC, 2018-12-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Abstract Background Few risk factors have been identified for the development of calcinosis among patients with Juvenile Dermatomyositis, and currently no clinical phenotype has been associated with its development. We analyzed a large database of patients to further elucidate any relationships amon...